Twin Tree Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,299
Closed -$5.66M 1882
2025
Q2
$5.1M Sell
23,299
-37,017
-61% -$7.91M 0.01% 996
2025
Q1
$13.5M Buy
+60,316
New +$16.6M 0.03% 563
2024
Q3
Sell
-3,182
Closed -$1.05M 1817
2024
Q2
$1.05M Buy
+3,182
New +$1.12M ﹤0.01% 1049
2024
Q1
Sell
-1,000
Closed -$352K 1655
2023
Q4
$352K Buy
+1,000
New +$354K ﹤0.01% 1227
2020
Q2
Sell
-1,140
Closed -$174K 1737
2020
Q1
$174K Buy
1,140
+313
+38% +$48.2K ﹤0.01% 1072
2019
Q4
$124K Buy
+827
New +$120K ﹤0.01% 1062
2019
Q3
Sell
-3,411
Closed -$470K 1549
2019
Q2
$427K Buy
+3,411
New +$403K ﹤0.01% 905
2018
Q3
Sell
-3,421
Closed -$340K 1319
2018
Q2
$340K Buy
+3,421
New +$315K ﹤0.01% 950
2017
Q1
Sell
-1,099
Closed -$93K 1296
2016
Q4
$93K Buy
+1,099
New +$86.4K ﹤0.01% 1042

Other funds holding WST

Twin Tree Management's WST Position: Q3 2025 in Review

Twin Tree Management sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 23,299 shares — an estimated $5.66M sold.

Twin Tree Management first reported a position in WST in Q4 2016 and held it in 9 quarters. The position peaked at $13.5M in Q1 2025. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Twin Tree Management reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Twin Tree Management sold 23,299 West Pharmaceutical shares in Q3 2025, an estimated $5.66M.
  • Twin Tree Management first reported a position in West Pharmaceutical in Q4 2016 and held it in 9 quarters.
  • Twin Tree Management's West Pharmaceutical position peaked at $13.5M in Q1 2025.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Twin Tree Management's 13F filing for Q3 2025, filed 13 Nov 2025.